Copy For Citation
Yalcin A. D., ÇİLLİ A., Bisgin A., Strauss L. G., Herth F.
EXPERT OPINION ON BIOLOGICAL THERAPY, vol.13, no.9, pp.1335-1341, 2013 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
13
Issue:
9
-
Publication Date:
2013
-
Doi Number:
10.1517/14712598.2013.819338
-
Journal Name:
EXPERT OPINION ON BIOLOGICAL THERAPY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.1335-1341
-
Keywords:
25-hydroxyvitamin D, asthma, cardiovascular risk, CXCL8, IL-1 beta, omalizumab, protein C and S deficiency, sCD200, PERSISTENT ALLERGIC-ASTHMA, EXHALED NITRIC-OXIDE, QUALITY-OF-LIFE, ANTI-IGE, IMMUNOGLOBULIN, STRAIL
-
Akdeniz University Affiliated:
Yes
Abstract
Background: There have been concerns about the cardiovascular safety of omalizumab.